Stock News

Citi downgrades Merck to neutral, says drug pipeline struggles will hold stock back


Medicine pill is seen with Merck logo displayed on a screen in the background in this illustration photo taken in Poland on October 4, 2021.

NurPhoto | NurPhoto | Getty Images

Disappointing results for some major drugs has limited the upside for Merck‘s stock, according to Citi.

Bitcoin climbs back above $57,000 as cryptocurrencies rebound from sell-off

Previous article

Zoom vs. Microsoft: ‘I don’t see why you would choose Zoom’ at these levels, trader says

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Stock News